Proposed Data Collections Submitted for Public Comment and Recommendations, 44334-44336 [2011-18705]
Download as PDF
jlentini on DSK4TPTVN1PROD with NOTICES
44334
Federal Register / Vol. 76, No. 142 / Monday, July 25, 2011 / Notices
will be selected for the Board. Nominees
are being accepted in the following
categories: Industry; academia,
practicing healthcare professional, and
organizations representing other
appropriate stakeholders. Submit a
resume or curriculum vitae
nbsb@hhs.gov by August 19, 2011.
FOR FURTHER INFORMATION CONTACT:
CAPT Leigh A. Sawyer, D.V.M., M.P.H.,
Executive Director, National Biodefense
Science Board, Office of the Assistant
Secretary for Preparedness and
Response, U.S. Department of Health
and Human Services, 330 C Street, SW.,
Switzer Building Room, 5127,
Washington, DC 20447; 202–205–3815;
fax: 202–205–8508; e-mail address:
leigh.sawyer@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d–7f) and
section 222 of the Public Health Service
Act (42 U.S.C. 217a), the Department of
Health and Human Services established
the National Biodefense Science Board.
The Board shall provide expert advice
and guidance to the Secretary on
scientific, technical, and other matters
of special interest to the Department of
Health and Human Services regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate. The Board may also
provide advice and guidance to the
Secretary and/or the Assistant Secretary
for Preparedness and Response (ASPR)
on other matters related to public health
emergency preparedness and response.
Description of Duties: The Board shall
advise the Secretary and/or ASPR on
current and future trends, challenges,
and opportunities presented by
advances in biological and life sciences,
biotechnology, and genetic engineering
with respect to threats posed by
naturally occurring infectious diseases
and chemical, biological, radiological,
and nuclear agents. At the request of the
Secretary and/or ASPR, the Board shall
review and consider any information
and findings received from the working
groups established under 42 U.S.C.
247d–7f(b). At the request of the
Secretary and/or ASPR, the Board shall
provide recommendations and findings
for expanded, intensified, and
coordinated biodefense research and
development activities. Additional
advisory duties concerning public
health emergency preparedness and
response may be assigned at the
discretion of the Secretary and/or ASPR.
Structure: The Board shall consist of
13 voting members, including the
Chairperson; additionally, there may be
non-voting ex officio members.
VerDate Mar<15>2010
16:15 Jul 22, 2011
Jkt 223001
Members and the Chairperson shall be
appointed by the Secretary from among
the Nation’s preeminent scientific,
public health and medical experts, as
follows: (a) Such Federal officials as the
Secretary determines are necessary to
support the functions of the Board, (b)
four individuals from the
pharmaceutical, biotechnology and
device industries, (c) four academicians,
and (d) five other members as
determined appropriate by the Secretary
and/or ASPR, one of whom must be a
practicing health care professional and
one of whom must be from an
organization representing health care
consumers. Additional members for
category (d), above, will be selected
from among State and local
governments and public health
agencies, emergency medical responders
and organizations representing other
appropriate stakeholders. A member of
the Board described in (b), (c), and (d)
in the above paragraph shall serve for a
term of 3 years, except that the Secretary
may adjust the terms of the initial Board
appointees in order to provide for a
staggered term of appointment of all
members. Members who are not fulltime
or permanent part-time Federal
employees shall be appointed by the
Secretary as Special Government
Employees.
Dated: July 18, 2011.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response, U.S. Department of Health and
Human Services.
[FR Doc. 2011–18756 Filed 7–22–11; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-11–11DE]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call the CDC Reports
Clearance Officer at 404–639–5960 or
send an e-mail to omb@cdc.gov. Send
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
written comments to CDC Desk Officer,
Office of Management and Budget,
Washington, DC or by fax to (202) 395–
5806. Written comments should be
received within 30 days of this notice.
Proposed Project
Communication Research on Folic
Acid to Support the Division of Birth
Defects and Developmental
Disabilities—New—National Center on
Birth Defects and Developmental
Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Since mandatory folic acid
fortification of cereal grain products was
mandated in 1998, rates of folic acidpreventable neural tube defects (NTDs)
have declined. Disparities in rates
remain, however, with NTD prevalence
being highest among Hispanic women of
childbearing age. Efforts to increase
consumption of vitamin supplements
containing folic acid among women in
this ethnic group have been ongoing,
however, due to differences in diet,
many of these women have not
benefitted from food fortification to the
extent that other race/ethnic groups
have. A performance goal for NCBDDD
focuses specifically on the reduction of
these disparities: Reduce health
disparities in the occurrence of folic
acid-preventable spina bifida and
anencephaly by reducing the birth
prevalence of these conditions.
Moreover, Healthy People 2010
objectives refer to the reduction of NTD
rates and increase of folic acid
consumption for all women of
childbearing age: (1) Reduce the
occurrence of spina bifida and other
NTDs; (2) Increase the proportion of
pregnancies begun with an optimum
folic acid level by increasing the
consumption of at least 400 mcg of folic
acid each day from fortified foods or
dietary supplements by nonpregnant
women aged 15 to 44 and increasing the
median red blood cell folate level
among nonpregnant women aged 15 to
44 years. The 2009 congressional
omnibus appropriations language
includes reference to reducing health
disparities: ‘‘There is significant
concern about disparity in the rates of
folic acid intake and neural tube
defects, particularly in the Hispanic
population. Within the funds provided
for folic acid, CDC is encouraged to
provide increased funding to expand the
folic acid education campaign to inform
more women and healthcare providers
about the benefits of folic acid * * *’’.
Finally, CDC partners are working to
develop a food additive petition that
will be submitted for approval to the
E:\FR\FM\25JYN1.SGM
25JYN1
44335
Federal Register / Vol. 76, No. 142 / Monday, July 25, 2011 / Notices
FDA. This petition would allow for the
addition of folic acid to corn masa flour
and corn masa flour products. Knowing
the consumer attitudes toward this
endeavor is important to the overall
success of the effort. Although up to
70% of neural tube defects can be
prevented if a woman consumes folic
acid before and during the first weeks of
pregnancy, many women are still
unaware of folic acid until they are
already pregnant. Because half of all
pregnancies in the U.S. are unplanned,
reaching women with the folic acid
message prior to pregnancy is critical.
NCBDDD currently has several folic acid
educational brochures, tip sheets, and
booklets available in both English and
Spanish. Since 2000, over 12 million
folic acid materials have been
distributed. Providing our partners,
health care providers, and the public
with evidence-based information in a
format that is easy to read and visually
appealing is important to the mission of
the Prevention Research team. We want
to ensure that the materials we currently
have available still meet the needs of the
intended audience.
CDC, with contract support from
Battelle Centers for Public Health
Research and Evaluation, is conducting
research to inform efforts to promote
folic acid consumptions among women
of child-bearing age through two
closely-related data collection efforts:
(1) Exploratory Research of Hispanic
Women’s Reactions to and Beliefs About
Folic Acid Fortification of Corn Masa
Flour, and (2) Exploratory Research of
Childbearing Age Women’s Folic Acid
Awareness and Knowledge, and their
Reactions to Existing CDC Folic Acid
Educational Materials. The purpose of
the first proposed primary data
collection effort is to better understand
consumer acceptance of fortifying corn
masa flour, a staple product in many
traditional Latino, and in particular
Mexican, foods. The purpose of the
second proposed primary data
collection effort is to determine whether
educational materials developed over 10
years ago to promote folic acid
consumption continue to be appealing
and resonate with the target audience
today. To address these two purposes
and support the folic acid education
efforts of CDC, focus groups with the
target audience are needed.
For the first data collection activity
phase, participants will be English and
Spanish-speaking women 18–44 years
who self identify as Mexican or Mexican
American, or Central American.
Participants will be segmented into
groups based on whether they consume
corn masa flour less than 4 times per
day or 4 or more times per day. The
contractor will conduct sixteen (16)
focus groups with five (5) participants
in each focus group. It is estimated that
320 respondents will have to be
screened in order to recruit 80 focus
group participants. Each screening will
take approximately 6 minutes. The
estimated response burden for the
screening process is 32 hours. The focus
group session will be structured to
identify women’s general awareness and
knowledge about folic acid and its role
in NTD prevention, perception of their
risk for having an affected pregnancy,
awareness and knowledge about
fortification of cereal grain products,
whether fortification of corn masa flour
products would change their current
reported use of these products, and
overall reaction to potential folic acid
fortification of these products.
For the second data collection activity
phase, focus group participants will be
women 18–44 years of age who are not
pregnant at the time of the focus groups,
who do not have a child with a birth
defect such as spina bifida or
anencephaly. The contractor will
conduct sixteen (16) focus groups with
five (5) participants in each focus group.
It is estimated that 320 respondents will
have to be screened in order to recruit
80 focus group participants. Each
screening will take approximately 6
minutes. The estimated response burden
for the screening process is 32 hours.
Participants will be segmented into
groups based on whether they selfidentify as either vitamin users (take a
vitamin containing folic acid 4–7 days
per week) or non-users (take a vitamin
containing folic acid less than 4 days
per week). The focus group session shall
be structured to identify women’s
awareness and knowledge about folic
acid, and how they would like to see
folic acid information portrayed in a
written format. Focus group participants
shall be shown written educational
materials that are currently being used
and asked questions designed to address
whether the materials are effective in
getting the folic acid message across to
the audience, whether the visual images
portrayed in the materials resonate with
the audience, and how the materials
could be improved. Also, differences
based on pregnancy contemplation
status shall be explored through
segmentation of the focus groups.
Sixteen focus groups will be
conducted in both phase one and phase
two, with a total of 80 participants in
each phase. The focus groups will have
five participants each. Each respondent
will participate in a 1.5-hour focus
group, for a total burden of 120 hours.
Data collection materials will be
available in both English and Spanish.
This request is being submitted to
obtain OMB clearance for one (1) year.
The total annualized burden for this
project is 304 hours. There are no costs
to respondents except for their time to
participate.
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
responses per
respondent
Number of
respondents
Average burden
per response
(in hours)
Form name
Women 18–44, Mexican or Central American heritage;
English and Spanish speakers.
Women 18–44, Mexican or Central American heritage;
English and Spanish speakers.
Women 18–44 (English speakers) ................................
Women 18–44 (English speakers) ................................
jlentini on DSK4TPTVN1PROD with NOTICES
Type of respondents
Project One Screener ........
320
1
Project One Focus Group
Guide.
Project Two Screener ........
Project Two Focus Group
Guide.
80
1
1.5
320
80
1
1
6/60
1.5
VerDate Mar<15>2010
16:15 Jul 22, 2011
Jkt 223001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\25JYN1.SGM
25JYN1
6/60
44336
Federal Register / Vol. 76, No. 142 / Monday, July 25, 2011 / Notices
Dated: July 18, 2011.
Daniel L. Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–18705 Filed 7–22–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–11–11FE]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Musculoskeletal Disorder (MSD)
Intervention Effectiveness in Wholesale/
Retail Trade Operations–New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
For the current study, the National
Institute for Occupational Safety and
Health (NIOSH) and the Ohio Bureau of
Workers Compensation (OBWC) will
collaborate on a multi-site intervention
study at OBWC-insured wholesale/retail
trade (WRT) companies from 2011–
2014. In overview, MSD engineering
control interventions [stair-climbing,
powered hand trucks (PHT) and
powered truck lift gates (TLG)] will be
tested for effectiveness in reducing selfreported back and upper extremity pain
among 960 employees performing
delivery operations in 72 WRT
establishments using a prospective
experimental design (multiple baselines
across groups with randomization). The
costs of the interventions will be funded
through existing OBWC funds and
participating establishments. This study
will provide important information that
is not currently available elsewhere on
the effectiveness of OSH interventions
for WRT workers.
Twenty-four OBWC-insured WRT
establishments will be recruited from
each of three total employee categories
(<20 employees, 20–99 employees, and
100+ employees) for a total of 72
establishments with 3,240 employees.
The study sub-sample (people, work
groups or workplaces chosen from the
sampling frame) will be volunteer
employees at OBWC-insured WRT
establishments who perform material
handling tasks related to the delivery
operations of large items (such as
appliances, furniture, vending
machines, furnaces, or water heaters)
that are expected to be impacted by the
powered hand truck (PHT) and truck lift
gate (TLG) interventions. It is estimated
that there will be 960 impacted
employees in the recruited
establishments, which will be paired
according to previous WC loss history
and establishment size. Within each
pair, one establishment will be
randomly chosen to receive the PHT or
TLG intervention in the first phase, and
the other will serve as a matched control
until it receives the same intervention
12 months later.
The main outcomes for this study are
self-reported low back pain and upper
extremity pain collected using surveys
every three months over a two-year
period from volunteer WRT delivery
workers at participating establishments.
Individuals will also be asked to report
usage of the interventions and material
handling exposures every three months
over two years. Individuals will also be
asked to complete an annual health
assessment survey at baseline, and once
annually for two years. A 20% sample
of survey participants will also be asked
to participate in a clinical assessment of
low back function at baseline, and once
annually for two years. In order to
maximize efficiency and reduce burden,
a Web-based survey is proposed for the
majority (95%) of survey data
collection. All collected information
will be used to determine whether there
are significant differences in reported
musculoskeletal pain and functional
back pain score ratios (pre/post
intervention scores) when intervention
and control groups are compared, while
controlling for covariates. Once the
study is completed, results will be made
available through the NIOSH Internet
site and peer-reviewed publications.
In summary, this study will determine
the effectiveness of the tested MSD
interventions for WRT delivery workers
and enable evidence based prevention
practices to be shared with the greatest
audience possible. NIOSH expects to
complete data collection in 2014. There
is no cost to respondents other than
their time. The total estimated annual
burden hours are 3,001.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hours)
Form name
Delivery Workers in Wholesale/Retail
Trade (WRT) Operations.
jlentini on DSK4TPTVN1PROD with NOTICES
Type of respondent
Self-reported low back pain .....................
960
9
5/60
Self-reported upper extremity pain ...........
Self-reported specific job tasks and safety incidents.
Self-reported general work environment
and health.
Informed Consent Form (Overall Study) ..
Low Back Functional Assessment ...........
Informed Consent Form (Low Back Functional Assessment).
Early Exit Interview ...................................
960
960
9
9
5/60
5/60
960
3
10/60
960
192
960
1
3
1
5/60
20/60
5/60
106
1
5/60
VerDate Mar<15>2010
16:15 Jul 22, 2011
Jkt 223001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\25JYN1.SGM
25JYN1
Agencies
[Federal Register Volume 76, Number 142 (Monday, July 25, 2011)]
[Notices]
[Pages 44334-44336]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18705]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-11-11DE]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer at 404-639-5960 or send an e-mail to omb@cdc.gov.
Send written comments to CDC Desk Officer, Office of Management and
Budget, Washington, DC or by fax to (202) 395-5806. Written comments
should be received within 30 days of this notice.
Proposed Project
Communication Research on Folic Acid to Support the Division of
Birth Defects and Developmental Disabilities--New--National Center on
Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Since mandatory folic acid fortification of cereal grain products
was mandated in 1998, rates of folic acid-preventable neural tube
defects (NTDs) have declined. Disparities in rates remain, however,
with NTD prevalence being highest among Hispanic women of childbearing
age. Efforts to increase consumption of vitamin supplements containing
folic acid among women in this ethnic group have been ongoing, however,
due to differences in diet, many of these women have not benefitted
from food fortification to the extent that other race/ethnic groups
have. A performance goal for NCBDDD focuses specifically on the
reduction of these disparities: Reduce health disparities in the
occurrence of folic acid-preventable spina bifida and anencephaly by
reducing the birth prevalence of these conditions. Moreover, Healthy
People 2010 objectives refer to the reduction of NTD rates and increase
of folic acid consumption for all women of childbearing age: (1) Reduce
the occurrence of spina bifida and other NTDs; (2) Increase the
proportion of pregnancies begun with an optimum folic acid level by
increasing the consumption of at least 400 mcg of folic acid each day
from fortified foods or dietary supplements by nonpregnant women aged
15 to 44 and increasing the median red blood cell folate level among
nonpregnant women aged 15 to 44 years. The 2009 congressional omnibus
appropriations language includes reference to reducing health
disparities: ``There is significant concern about disparity in the
rates of folic acid intake and neural tube defects, particularly in the
Hispanic population. Within the funds provided for folic acid, CDC is
encouraged to provide increased funding to expand the folic acid
education campaign to inform more women and healthcare providers about
the benefits of folic acid * * *''. Finally, CDC partners are working
to develop a food additive petition that will be submitted for approval
to the
[[Page 44335]]
FDA. This petition would allow for the addition of folic acid to corn
masa flour and corn masa flour products. Knowing the consumer attitudes
toward this endeavor is important to the overall success of the effort.
Although up to 70% of neural tube defects can be prevented if a woman
consumes folic acid before and during the first weeks of pregnancy,
many women are still unaware of folic acid until they are already
pregnant. Because half of all pregnancies in the U.S. are unplanned,
reaching women with the folic acid message prior to pregnancy is
critical. NCBDDD currently has several folic acid educational
brochures, tip sheets, and booklets available in both English and
Spanish. Since 2000, over 12 million folic acid materials have been
distributed. Providing our partners, health care providers, and the
public with evidence-based information in a format that is easy to read
and visually appealing is important to the mission of the Prevention
Research team. We want to ensure that the materials we currently have
available still meet the needs of the intended audience.
CDC, with contract support from Battelle Centers for Public Health
Research and Evaluation, is conducting research to inform efforts to
promote folic acid consumptions among women of child-bearing age
through two closely-related data collection efforts: (1) Exploratory
Research of Hispanic Women's Reactions to and Beliefs About Folic Acid
Fortification of Corn Masa Flour, and (2) Exploratory Research of
Childbearing Age Women's Folic Acid Awareness and Knowledge, and their
Reactions to Existing CDC Folic Acid Educational Materials. The purpose
of the first proposed primary data collection effort is to better
understand consumer acceptance of fortifying corn masa flour, a staple
product in many traditional Latino, and in particular Mexican, foods.
The purpose of the second proposed primary data collection effort is to
determine whether educational materials developed over 10 years ago to
promote folic acid consumption continue to be appealing and resonate
with the target audience today. To address these two purposes and
support the folic acid education efforts of CDC, focus groups with the
target audience are needed.
For the first data collection activity phase, participants will be
English and Spanish-speaking women 18-44 years who self identify as
Mexican or Mexican American, or Central American. Participants will be
segmented into groups based on whether they consume corn masa flour
less than 4 times per day or 4 or more times per day. The contractor
will conduct sixteen (16) focus groups with five (5) participants in
each focus group. It is estimated that 320 respondents will have to be
screened in order to recruit 80 focus group participants. Each
screening will take approximately 6 minutes. The estimated response
burden for the screening process is 32 hours. The focus group session
will be structured to identify women's general awareness and knowledge
about folic acid and its role in NTD prevention, perception of their
risk for having an affected pregnancy, awareness and knowledge about
fortification of cereal grain products, whether fortification of corn
masa flour products would change their current reported use of these
products, and overall reaction to potential folic acid fortification of
these products.
For the second data collection activity phase, focus group
participants will be women 18-44 years of age who are not pregnant at
the time of the focus groups, who do not have a child with a birth
defect such as spina bifida or anencephaly. The contractor will conduct
sixteen (16) focus groups with five (5) participants in each focus
group. It is estimated that 320 respondents will have to be screened in
order to recruit 80 focus group participants. Each screening will take
approximately 6 minutes. The estimated response burden for the
screening process is 32 hours. Participants will be segmented into
groups based on whether they self-identify as either vitamin users
(take a vitamin containing folic acid 4-7 days per week) or non-users
(take a vitamin containing folic acid less than 4 days per week). The
focus group session shall be structured to identify women's awareness
and knowledge about folic acid, and how they would like to see folic
acid information portrayed in a written format. Focus group
participants shall be shown written educational materials that are
currently being used and asked questions designed to address whether
the materials are effective in getting the folic acid message across to
the audience, whether the visual images portrayed in the materials
resonate with the audience, and how the materials could be improved.
Also, differences based on pregnancy contemplation status shall be
explored through segmentation of the focus groups.
Sixteen focus groups will be conducted in both phase one and phase
two, with a total of 80 participants in each phase. The focus groups
will have five participants each. Each respondent will participate in a
1.5-hour focus group, for a total burden of 120 hours. Data collection
materials will be available in both English and Spanish. This request
is being submitted to obtain OMB clearance for one (1) year. The total
annualized burden for this project is 304 hours. There are no costs to
respondents except for their time to participate.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response (in
respondents respondent hours)
----------------------------------------------------------------------------------------------------------------
Women 18-44, Mexican or Central Project One Screener. 320 1 6/60
American heritage; English and
Spanish speakers.
Women 18-44, Mexican or Central Project One Focus 80 1 1.5
American heritage; English and Group Guide.
Spanish speakers.
Women 18-44 (English speakers).... Project Two Screener. 320 1 6/60
Women 18-44 (English speakers).... Project Two Focus 80 1 1.5
Group Guide.
----------------------------------------------------------------------------------------------------------------
[[Page 44336]]
Dated: July 18, 2011.
Daniel L. Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-18705 Filed 7-22-11; 8:45 am]
BILLING CODE 4163-18-P